Cambium, an El Segundo, CA-based advanced materials innovator for defense and other high-performance fields, raised $19M in Series A funding.
The round was led by 8VC, with participation from Veteran Ventures, GSBackers, Marlinspike, MVP Ventures, Gaingels, Kern Venture Fund, Jackson Moses (Founder, Silent Ventures), Vertical Capital, and angel investors.
The company intends to use the funds to build out staffing and R&D, rapid discovery-to-field demonstrations, and pilot-scale manufacturing.
Led by CEO Simon Waddington, Cambium is an advanced materials innovator for defense and other high-performance fields. It is an one-stop shop for vertically-integrated innovation, from computational material discovery through to production of advanced composites in the US. The company leverages advances in biology, chemistry, materials science, and AI-enhanced product development to accelerate the deployment of products. Cambium’s Thermal Protection Systems (TPS) are designed and fabricated to protect various hardware against extreme conditions such as heat, fire and rapid-heating impacts, and from severe aerodynamic heating and pressure loads experienced during flight.
Cambium’s contracts include BioMADE (a prime contractor), as well as the bio-manufacturing arm of the Department of Defense (DoD), which drives the transition of bio-for-defense (B4D) products from the laboratory to defense and commercial markets. The company also works closely with the U.S. Naval Air Warfare Center Weapons Division and the U.S. Office of the Under Secretary of Defense for Research and Engineering to develop a range of new high-performance biomaterials that can be industry certified and integrated into a broad set of high-value defense and aerospace performance systems. These range from hypersonic flight vehicles to enhanced survivability unmanned aerial vehicles to laser-protective eyewear and optics.
FinSMEs
05/12/2023